Quarterly Results

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE1035.7513.7 (+1.34 %)
PREV CLOSE ( ) 1022.05
OPEN PRICE ( ) 1026.35
BID PRICE (QTY) 1034.55 (32)
OFFER PRICE (QTY) 1035.55 (4)
VOLUME 89516
TODAY'S LOW / HIGH ( )1026.35 1058.95
52 WK LOW / HIGH ( )564.2 1107.85
NSE1034.6513.5 (+1.32 %)
PREV CLOSE( ) 1021.15
OPEN PRICE ( ) 1030.00
BID PRICE (QTY) 1034.65 (2)
OFFER PRICE (QTY) 1035.00 (707)
VOLUME 1046732
TODAY'S LOW / HIGH( ) 1025.00 1059.00
52 WK LOW / HIGH ( )564 1108.35
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
7586
10314
11405
8979
Total Expenditure
4905
5734
6125
5588
PBIDT (Excl OI)
2681
4580
5280
3391
Other Income
370
294
197
290
Operating Profit
3051
4874
5477
3681
Interest
46
42
42
27
Exceptional Items
NA
NA
NA
NA
PBDT
3005
4832
5435
3654
Depreciation
442
436
435
410
Profit Before Tax
2563
4396
5000
3244
Tax
436
706
797
486
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2127
3690
4203
2758
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
2127
3690
4203
2758
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
2127
3690
4203
2758
Equity Capital
358
358
358
365
Face Value (IN RS)
2
2
2
2
Reserves
NA
NA
NA
NA
Calculated EPS
11.88
20.61
23.48
15.11
Calculated EPS (Annualised)
47.53
82.45
93.92
60.44
No of Public Share Holdings
90079595
90079295
89989295
93349540
% of Public Share Holdings
50.29
50.29
50.24
51.16
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
35.34
44.40
46.29
37.76
PBIDTM%
40.21
47.25
48.02
40.99
PBDTM%
39.61
46.84
47.65
40.69
PBTM%
33.78
42.62
43.84
36.12
PATM%
28.03
35.77
36.85
30.71
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.